Reply to: “Alkaline phosphatases as a potential source of variability in foslevodopa response: Muscles beyond pharmacokinetics”

2026-08-10

PRE

Manon Auffret PharmD, PhD, DAAN *

Marc Vérin MD, PhD

DOI：10.1002/mds.70450

Original request for help

Save

Abstract

Keywords:

alkaline phosphatases

device-aided therapies

foslevodopa/foscarbidopa

Parkinson's disease

pharmacokinetics

IF:

7.6

Papers:

1.1W

Citations:

3.3W

Scholars:

Papers: 2

Citations: 0

Scholars:

Papers: 21

Citations: 5.2K